Subscribe

Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine Search
The flaw that landed Sanofi a win in the rare disease space
Europe
The flaw that landed Sanofi a win in the rare disease space
The company’s EPO victory over a rare disease biomarker patent highlights how precise claims and attention to objections can make or break biotech cases, reports Marisa Woutersen.   4 September 2025
Roche resolves cancer test dispute with Stanford affiliated startup
Americas
Roche resolves cancer test dispute with Stanford affiliated startup
The deal brings to a close a clash over DNA sequencing technology for cancer detection, with both sides agreeing to dismiss their claims.   4 September 2025
Why Masimo’s ‘rare’ move pushes Apple case into uncharted territory
Americas
Why Masimo’s ‘rare’ move pushes Apple case into uncharted territory
The company’s decision to sue US customs may result in a “roadmap” to sidestep ITC orders—and patent litigators are watching, finds Marisa Woutersen.   3 September 2025
Europe
UK firm expands in Germany with more litigation hires
Carpmaels & Ransford appoints two litigation partners as the UK firm expands its presence in Germany in response to UPC demand.   3 September 2025
Europe
Sandoz blocked by UK court from seeking Xarelto profits
A High Court decision clarifies how cross-undertakings work in patent disputes, rejecting claims for exceptional remedies beyond compensation.   2 September 2025
Biotechnology
An update on patenting in Ukraine, Russia and Eurasia
Erik Viik of Papula-Nevinpat looks at the dynamics that international applicants need to be aware of to secure and manage their patent rights across the region.   2 September 2025
Americas
The rise of pro-NPE and patent sentiment in the US
Non-practising entities are controversial, but political winds in the US are shifting and inventors, investors, and operating companies of all stripes should take note, writes Manny Caixeiro of Venable.   1 September 2025
Europe
UPC sees rising small molecule litigation with Pfizer in the hot seat
A rare “innovator v innovator” case puts Pfizer in the firing line over its COVID-19 drug, highlighting the Unified Patent Court as an attractive forum for ‘David vs Goliath’ scenarios, say experts.   29 August 2025
Americas
Why the Caribbean cannabis economy is ripe for IP protection
With growing legislation, research and demand for medical use, cannabis presents an economic opportunity for the Caribbean—but IP rights in the region have some way to go, write Keesha Fleming Lake of Keesha Fleming Lake, and Rachael Lodge Corrie of Foga Daley.   28 August 2025
Europe
China filings push rise in patent applications in Ireland
A high number of filings from China has driven patent applications up by nearly a third at Ireland’s intellectual property office, which also reported a rise in SPC applications and strong activity in the medtech sector.   28 August 2025